Navigating DTC Marketing Challenges: Key Questions for Success

The debate around DTC marketing continues, but how patients make treatment decisions has significantly changed. Today, insurers (PBMs) have a more significant say in medications patients use, and mistrust in pharma continues to be very high. So, what questions should DTC marketers be asking?

1ne: What do we know about our target audience(s)? Where do they go online to validate medical information and ask questions, and how will our DTC affect their behavior? The journey from awareness to getting an Rx is more complicated than ever. Can your DTC connect the dots between awareness and getting an Rx?

2wo: What is the reason to believe? Stating that 30% of patients saw improvement with a new treatment does not work because 70% did not. Do you really understand what’s needed to get them to take action? Too many DTC marketers continue to tout their market research, but there are huge disconnects between focus groups and real life.

3hree: Do we have a patient journey mapped, and can we influence it? Clickstream analysis shows that patients look at many online sites before making decisions. Are you willing to listen to what they say on social media and act on those conversations?

4our: Is TV the best way to reach our audience? I can show clients data that clearly indicates their TV spend is wasted money. Yes, it raises awareness of new treatments, but DTC marketers ignore the connection between awareness and conversion.

5ive: Do physicians understand what we communicate to patients, and are they on board? This is a critical element of DTC marketing. Patients still see their doctors as the “gatekeepers” and trust them to determine the best course of treatment.

6ix: Can we develop a copy that talks to patients and doesn’t sound like a medical journal? In Reserac, this is the biggest complaint we consistently hear.

7even: Does our agency understand our audience and what success looks like? If you treat them like vendors, they will act and do what you tell them. If you treat them like partners, they will act like they have a stake in the outcome.

8eight: Am I willing to push back and say, “TV is not the primary channel for this product?” Too many are not and want the glory of developing a TV ad campaign even though it doesn’t make sense.

9ine: Does your brand team understand adaptive marketing? As your product moves through its life cycle, the message(s) may need to change because of changes in market conditions. Do your people understand this, or will it take months of research and meetings to adapt while the market moves on?

10en: Do I have in-house digital marketing experts who can help me with meaningful online metrics and ensure our budget is not wasted? More than 50% of your online ad budget is wasted by fraud and meaningless metrics. You need a digital marketing person on staff.

DTC marketing is not science; it’s art built on understanding our current challenges. Too many DTC marketers don’t get that. They get caught up in meetings and corporate politics. It’s time to change that.

About Richard Meyer

I’m Richard Meyer — a 25 year healthcare marketing strategist and writer focused on the intersection of direct-to-consumer marketing, healthcare economics, and human behavior.I started Work of DTC Marketing because too much of the conversation around pharma and healthcare marketing is either overly promotional, overly technical, or completely disconnected from how the system actually works.Here, I write about what DTC really does, how incentives drive behavior inside healthcare organizations, why patients are often treated like revenue streams instead of people, and why “best practices” are frequently just recycled assumptions.My background spans digital marketing, public relations, and healthcare strategy, and my approach is pragmatic, skeptical of hype, and grounded in data and lived experience. I’m less interested in what sounds good in a deck and more interested in what actually changes outcomes — for companies, doctors, and especially patients.

View all posts by Richard Meyer →

Leave a Reply